ta 0910 has been researched along with Ataxia in 6 studies
*Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Abe, Y; Ijiro, T; Kiguchi, S; Yaguchi, A; Yokoyama, A | 1 |
Honda, M; Kimura, S; Nakamura, T; Oda, S; Ono, H; Tanabe, M | 1 |
Fujitsuka, T; Kinoshita, K; Matsuoka, Y; Yamamura, M | 1 |
Asai, H; Kinoshita, K; Matsuoka, Y; Watanabe, Y; Yamamura, M | 1 |
Fukushima, T; Kinoshita, K; Kodama, Y; Matsuoka, Y; Sugihara, J; Yamamura, M | 1 |
Kinoshita, K; Sugihara, J; Yamamura, M | 1 |
6 other study(ies) available for ta 0910 and Ataxia
Article | Year |
---|---|
Ameliorating effect of rovatirelin on the ataxia in rolling mouse Nagoya.
Topics: Animals; Ataxia; Behavior, Animal; Brain; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Female; Glucose; Male; Mice; Oxazolidinones; Pyrrolidines; Spinocerebellar Degenerations; Thyrotropin-Releasing Hormone | 2020 |
Taltirelin improves motor ataxia independently of monoamine levels in rolling mouse nagoya, a model of spinocerebellar atrophy.
Topics: Animals; Ataxia; Biogenic Monoamines; Brain Stem; Cerebellum; Disease Models, Animal; Drug Administration Schedule; Mice; Mice, Neurologic Mutants; Nootropic Agents; Spinal Cord; Spinocerebellar Ataxias; Thyrotropin-Releasing Hormone | 2005 |
Effects of TA-0910, a novel orally active thyrotropin-releasing hormone analog, on the gait of ataxic animals.
Topics: Administration, Oral; Analysis of Variance; Animals; Ataxia; Cerebellum; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gait; Inferior Colliculi; Male; Mice; Mice, Neurologic Mutants; Pyridines; Rats; Rats, Wistar; Spinal Cord Compression; Thoracic Vertebrae; Thyrotropin-Releasing Hormone | 1995 |
Anti-ataxic effects of TRH and its analogue, TA-0910, in Rolling mouse Nagoya by metabolic normalization of the ventral tegmental area.
Topics: Animals; Ataxia; Energy Metabolism; Glucose; Male; Mice; Mice, Neurologic Mutants; Motor Activity; Thyrotropin-Releasing Hormone; Ventral Tegmental Area | 1995 |
Chronic anti-ataxic actions of the novel thyrotropin-releasing hormone (TRH) analog, TA-0910, during and after repeated administration in Rolling mouse Nagoya: behavioral and pharmacokinetic studies.
Topics: Animals; Ataxia; Behavior, Animal; Male; Mice; Mice, Mutant Strains; Nootropic Agents; Thyrotropin-Releasing Hormone | 1997 |
Distribution of thyrotropin-releasing hormone (TRH) receptors in the brain of the ataxic mutant mouse, rolling mouse Nagoya.
Topics: Animals; Ataxia; Brain Chemistry; Male; Mice; Mice, Mutant Strains; Receptors, Thyrotropin-Releasing Hormone; Thyrotropin-Releasing Hormone | 1997 |